E. Mayhew

Materials Science · Physical Sciences

42h-index7.3kcitations135works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoparticle-Based Drug Delivery(27), RNA Interference and Gene Delivery(22), Lipid Membrane Structure and Behavior(16), Drug Transport and Resistance Mechanisms(13), Glycosylation and Glycoproteins Research(12)

Publications135 total

Contributors
Elsevier eBooks·2023
Contributors
Elsevier eBooks·2019
Hydrolyzable hydrophobic taxanes: synthesis and anti-cancer activities
Anti-Cancer Drugs·2001· 28 cited
Novel therapeutic nano-particles (lipocores): trapping poorly water soluble compounds
International Journal of Pharmaceutics·2000· 70 cited
Increased cell-surface receptor expression on U-937 cells induced by 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine
Cancer Immunology Immunotherapy·2000· 12 citedOpen Access
A Differential Scanning Calorimetry Study of Phosphocholines Mixed with Paclitaxel and Its Bromoacylated Taxanes
Biophysical Journal·2000· 85 citedOpen Access
INHIBITION OF CELL DIVISION BUT NOT NUCLEAR DIVISION BY 1‐ <i>O</i> ‐OCTADECYL‐2‐ <i>O</i> ‐METHYL‐ <i>Sn</i> ‐GLYCERO‐3‐PHOSPHOCHOLINE
Cell Biology International·1999· 11 cited
Liposomal ET-18-OCH3 Induces Cytochrome c-Mediated Apoptosis Independently of CD95 (APO-1/Fas) Signaling
Blood·1999· 38 cited
Growth inhibition of a human ovarian tumor by a novel paclitaxel derivative in SCID mice.
PubMed·1999· 6 cited
Growth inhibitory effects of liposome‐associated 1‐<i>O</i>‐octadecyl‐2‐<i>O</i>‐methyl‐<i>sn</i>‐glycero‐3‐phosphocholine
Lipids·1997· 16 cited
Stability of association of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine with liposomes is composition dependent
Biochimica et Biophysica Acta (BBA) - Biomembranes·1997· 14 cited
Combination of antitumor ether lipid with lipids of complementary molecular shape reduces its hemolytic activity
Biochimica et Biophysica Acta (BBA) - Biomembranes·1997· 42 cited
Activity of paclitaxel liposome formulations against human ovarian tumor xenografts
International Journal of Cancer·1997· 136 citedOpen Access
ChemInform Abstract: Synthesis and Growth Inhibitory Properties of Glycosides of 1‐O‐ Hexadecyl‐2‐O‐methyl‐sn‐glycerol, Analogues of the Antitumor Ether Lipid ET‐18‐OCH3 (Edelfosine).
ChemInform·1996· 9 cited
Synthesis and Growth Inhibitory Properties of Glycosides of 1-<i>O</i>-Hexadecyl-2-<i>O</i>-methyl-<i>sn</i>-glycerol, Analogs of the Antitumor Ether Lipid ET-18-OCH<sub>3</sub> (Edelfosine)
Journal of Medicinal Chemistry·1996· 36 cited
Pharmacokinetics and anti‐tumor activity of vincristine encapsulated in sterically stabilized liposomes
International Journal of Cancer·1995· 79 cited
Modulation of the antitumour activity of cisplatin alone and in combination with 5-fluoro-2'-deoxyuridine by N-phosphonacetyl-l-aspartate in murine colon carcinoma no. 26
European Journal of Cancer·1995· 2 cited
Cancer is the problem
Journal of Liposome Research·1995· 1 cited
Pharmacokinetics, Biodistribution and Therapeutic Efficacy of Doxorubicin Encapsulated in Stealth® Liposomes (Doxil®)
Journal of Liposome Research·1994· 159 cited
Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes
Cancer·1993· 103 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

L. Weiss(6), Demetrios Papahadjopoulos(5), Youcef M. Rustum(5), Jan Vaage(5), D. Papahadjopoulos(5), Andrew S. Janoff(5), D. D. Lasič(4), William J. Vail(4), Harold K. Kimelberg(4), S.K. Huang(3), Martin C. Woodle(3), C. Dave(3), Theresa M. Allen(2), Francis C. Szoka(2), Fred C. Olson(2), Francisco J. Plaza Martín(2), Mary S. Newman(2), George Poste(2), A. Sharma(2), R M Straubinger(2)